| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |